Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AiRXOS is a technology company specializing in Unmanned Aircraft System Traffic Management (UTM) and air mobility solutions, originally established as a venture of GE Aviation. The company provides the 'Air Mobility Platform,' which enables safe and compliant drone operations, including Beyond Visual Line of Sight (BVLOS) flights. Within the healthcare and life sciences sectors, AiRXOS has played a critical role in developing the infrastructure for medical drone logistics, notably facilitating the first-ever drone delivery of a human organ for transplant. Their services help healthcare systems and organ procurement organizations improve the speed and reliability of transporting time-critical medical supplies. In 2022, AiRXOS was acquired by SITA to integrate its UTM capabilities into SITA's broader aviation technology portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AiRXOS.